These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31755808)

  • 21. Antibacterial activity and synergistic effect between watercress extracts, 2-phenylethyl isothiocyanate and antibiotics against 11 isolates of Escherichia coli from clinical and animal source.
    Freitas E; Aires A; de Santos Rosa EA; Saavedra MJ
    Lett Appl Microbiol; 2013 Oct; 57(4):266-73. PubMed ID: 23682789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic antibacterial activity of the combination of the alkaloid sanguinarine with EDTA and the antibiotic streptomycin against multidrug resistant bacteria.
    Hamoud R; Reichling J; Wink M
    J Pharm Pharmacol; 2015 Feb; 67(2):264-73. PubMed ID: 25495516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efflux pump inhibitor phenylalanine-arginine β-naphthylamide (PAβN) increases resistance to carbapenems in Chilean clinical isolates of KPC-producing Klebsiella pneumoniae.
    Vera-Leiva A; Carrasco-Anabalón S; Lima CA; Villagra N; Domínguez M; Bello-Toledo H; González-Rocha G
    J Glob Antimicrob Resist; 2018 Mar; 12():73-76. PubMed ID: 29275225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptation of clinical isolates of Klebsiella pneumoniae to the combination of niclosamide with the efflux pump inhibitor phenyl-arginine-β-naphthylamide (PaβN): co-resistance to antimicrobials.
    Pacios O; Fernández-García L; Bleriot I; Blasco L; Ambroa A; López M; Ortiz-Cartagena C; González de Aledo M; Fernández-Cuenca F; Oteo-Iglesias J; Pascual Á; Martínez-Martínez L; Tomás M
    J Antimicrob Chemother; 2022 Apr; 77(5):1272-1281. PubMed ID: 35238930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phenylalanine-arginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides.
    Mamelli L; Amoros JP; Pagès JM; Bolla JM
    Int J Antimicrob Agents; 2003 Sep; 22(3):237-41. PubMed ID: 13678827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibacterial secondary metabolites from
    Jepkoech C; Omosa LK; Nchiozem-Ngnitedem VA; Kenanda EO; Guefack MF; Mbaveng AT; Kuete V; Heydenreich M
    Nat Prod Res; 2022 Jun; 36(12):3203-3206. PubMed ID: 34293972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli.
    Kern WV; Steinke P; Schumacher A; Schuster S; von Baum H; Bohnert JA
    J Antimicrob Chemother; 2006 Feb; 57(2):339-43. PubMed ID: 16354747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevant role of efflux pumps in high levels of rifaximin resistance in Escherichia coli clinical isolates.
    Gomes C; Ruiz L; Pons MJ; Ochoa TJ; Ruiz J
    Trans R Soc Trop Med Hyg; 2013 Sep; 107(9):545-9. PubMed ID: 23843564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antibacterial activities of p-toluenesulfonyl-hydrazinothiazoles and hydrazinoselenazoles against multi-drug resistant Gram-negative phenotypes.
    Mbaveng AT; Ignat AG; Ngameni B; Zaharia V; Ngadjui BT; Kuete V
    BMC Pharmacol Toxicol; 2016 Jan; 17():3. PubMed ID: 26782344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rifaximin resistance in Escherichia coli associated with inflammatory bowel disease correlates with prior rifaximin use, mutations in rpoB, and activity of Phe-Arg-β-naphthylamide-inhibitable efflux pumps.
    Kothary V; Scherl EJ; Bosworth B; Jiang ZD; Dupont HL; Harel J; Simpson KW; Dogan B
    Antimicrob Agents Chemother; 2013 Feb; 57(2):811-7. PubMed ID: 23183443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fitness and molecular mechanisms of resistance to rifaximin in in vitro selected Escherichia coli mutants.
    Pons MJ; Mensa L; Gascón J; Ruiz J
    Microb Drug Resist; 2012 Aug; 18(4):376-9. PubMed ID: 21711150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geraniol restores antibiotic activities against multidrug-resistant isolates from gram-negative species.
    Lorenzi V; Muselli A; Bernardini AF; Berti L; Pagès JM; Amaral L; Bolla JM
    Antimicrob Agents Chemother; 2009 May; 53(5):2209-11. PubMed ID: 19258278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the inhibitors phenylalanine arginyl ß-naphthylamide (PAßN) and 1-(1-naphthylmethyl)-piperazine (NMP) on expression of genes in multidrug efflux systems of Escherichia coli isolates from bovine mastitis.
    Barrero MA; Pietralonga PA; Schwarz DG; Silva A; Paula SO; Moreira MA
    Res Vet Sci; 2014 Oct; 97(2):176-81. PubMed ID: 24992822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activity of the efflux pump inhibitor phenylalanine-arginine β-naphthylamide against the AdeFGH pump of Acinetobacter baumannii.
    Cortez-Cordova J; Kumar A
    Int J Antimicrob Agents; 2011 May; 37(5):420-4. PubMed ID: 21377839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro development and analysis of Escherichia coli and Shigella boydii azithromycin-resistant mutants.
    Gomes C; Pons MJ; Magallon-Tejada A; Durand D; Lluque A; Mosquito S; Riveros M; Mercado E; Prada A; Ochoa TJ; Ruiz J
    Microb Drug Resist; 2013 Apr; 19(2):88-93. PubMed ID: 23176550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
    Bohnert JA; Schuster S; Fähnrich E; Trittler R; Kern WV
    J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single and joint antibacterial activity of aqueous garlic extract and Manuka honey on extended-spectrum beta-lactamase-producing Escherichia coli.
    Idris AR; Afegbua SL
    Trans R Soc Trop Med Hyg; 2017 Oct; 111(10):472-478. PubMed ID: 29373742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoacyl β-naphthylamides as substrates and modulators of AcrB multidrug efflux pump.
    Kinana AD; Vargiu AV; May T; Nikaido H
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1405-10. PubMed ID: 26787896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey.
    Hasdemir UO; Chevalier J; Nordmann P; Pagès JM
    J Clin Microbiol; 2004 Jun; 42(6):2701-6. PubMed ID: 15184455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.